(Q33330195)

English

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Philip W. Kantoff

5

object named as

Kantoff PW

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Oh WK

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Manola J

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Richie JP

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Loughlin KR

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1329-1334

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Metastatic bladder cancer: advances in treatment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Chemotherapy of urothelial tract tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Systemic chemotherapy of transitional cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Long-term results with M-VAC for advanced urothelial cancer: high relapse rate and low survival in patients with a complete response

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Treatment of advanced bladder carcinoma with irradiation and concomitant 5-fluorouracil infusion

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19991001)86:7<1329::AID-CNCR31>3.0.CO;2-R

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33330195&oldid=1773390449"